![Russell Beyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell P.
Beyer is currently the Chief Financial Officer at SAB Sciences, Inc. He previously held the same position at SAB Biotherapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Chief Financial Officer at Big Cypress Acquisition Corp.
Mr. Beyer received an undergraduate degree from St. Lawrence University and an MBA from the University of Rochester Simon Business School.
| Empresas | Cargo | Inicio |
|---|---|---|
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Director Financiero/CFO | 01/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 27/10/2023 |
| BIG CYPR | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
 University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
